Skip to main content
SpringerLink
Log in
Book cover

Isolation and Molecular Characterization of Circulating Tumor Cells pp 229–245Cite as

Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 994))

Abstract

Cancer patients die of metastatic disease but knowledge regarding individual steps of this complex process of intravasation, spread and extravasation leading to secondary lesions is incomplete. Subpopulations of tumor cells are supposed to undergo an epithelial-mesenchymal transition (EMT), to enter the bloodstream and eventually establish metastases in a reverse process termed mesenchymal-epithelial transition (MET). Small cell lung cancer (SCLC) represents a unique model to study metastatic spread due to early dissemination and relapse, as well as availability of a panel of circulating cancer cell (CTC) lines recently. Additionally, chemosensitive SCLC tumor cells switch to a completely resistant phenotype during cancer recurrence. In advanced disease, SCLC patients display extremely high blood counts of CTCs in contrast to other tumors, like breast, prostate and colon cancer. Local inflammatory conditions at the primary tumor site and recruitment of macrophages seem to increase the shedding of tumor cells into the circulation in processes which may proceed independently of EMT. Since millions of cells are released by tumors into the circulation per day, analysis of a limited number of CTCs at specific time points are difficult to be related to the development of metastatic lesions which may occur approximately one year later. We have obtained a panel of SCLC CTC cell line from patients with relapsing disease, which share characteristic markers of this malignancy and a primarily epithelial phenotype with unique formation of large tumorospheres, containing quiescent and hypoxic cells. Although smoking and inflammation promote EMT, partial expression of vimentin indicates a transitional state with partial EMT in these cell lines at most. The CTC lines exhibit high expression of EpCAM , absent phosphorylation of β-catenin and background levels of Snail. Provided that these tumor cells had ever undergone EMT, here in advanced disease MET seem to have occurred already in the peripheral circulation. Alternative explanations for the expression of mesenchymal markers of the CTC lines are the heterogeneity of SCLC cells, cooperative migration or altered gene expression in response to the inflammatory tumor microenvironment allowing for tumor spread without EMT/MET.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Aceto N, Bardia A, Miyamoto DT et al (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5):1110–1122

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alix-Panabières C, Pantel K (2016) Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov 6(5):479–491

    Article  PubMed  CAS  Google Scholar 

  • Allan AL, Keeney M (2010) Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol 2010:426218

    Article  PubMed  Google Scholar 

  • Armstrong AJ, Marengo MS, Oltean S et al (2011) Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9(8):997–1007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Asai N, Ohkuni Y, Kaneko N et al (2014) Relapsed small cell lung cancer: treatment options and latest developments. Ther Adv Med Oncol 6(2):69–82

    Article  PubMed  PubMed Central  Google Scholar 

  • Barriere G, Fici P, Gallerani G et al (2014) Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. Ann Transl Med 2(11):109

    PubMed  PubMed Central  Google Scholar 

  • Benes P, Macecková V, Zdráhal Z et al (2006) Role of vimentin in regulation of monocyte/macrophage differentiation. Differentiation 74(6):265–276

    Article  CAS  PubMed  Google Scholar 

  • Blassl C, Kuhlmann JD, Webers A et al (2016) Gene expression profiling of single circulating tumor cells in ovarian cancer—establishment of a multi-marker gene panel. Mol Oncol 10(7):1030–1042

    Article  CAS  PubMed  Google Scholar 

  • Bonnomet A, Syne L, Brysse A et al (2012) A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene 31(33):3741–3753

    Article  CAS  PubMed  Google Scholar 

  • Brabletz T, Jung A, Reu S et al (2001) Variable beta-catenin expression in in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 98(18):10356–10361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brabletz T, Jung A, Spaderna S et al (2005) Opinion: migrating cancer stem cells – an integrated concept of malignant tumour progression. Nat Rev Cancer 5(9):744–749

    Article  CAS  PubMed  Google Scholar 

  • Butler TP, Gullino PM (1975) Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35(3):512–516

    CAS  PubMed  Google Scholar 

  • Byers LA, Rudin CM (2015) Small cell lung cancer: where do we go from here? Cancer 121(5):664–672

    Article  CAS  PubMed  Google Scholar 

  • Byers LA, Diao L, Wang J et al (2013) An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 19(1):279–290

    Article  CAS  PubMed  Google Scholar 

  • Calbo J, van Montfort E, Proost N et al (2011) A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell 19(2):244–256

    Article  CAS  PubMed  Google Scholar 

  • Cano A, Perez-Moreno MA, Rodrigo I et al (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2(2):76–83

    Article  CAS  PubMed  Google Scholar 

  • Celià-Terrassa T, Kang Y (2016) Distinctive properties of metastasis-initiating cells. Genes Dev 30(8):892–908

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572

    Article  CAS  PubMed  Google Scholar 

  • Chang CJ, Chao CH, Xia W et al (2011) p53 regulates epithelial-mesenchymal and stem cell properties through modulating miRNAs. Nat Cell Biol 13(3):317–323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chao Y, Wu Q, Shepard C, Wells A (2012) Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clin Exp Metastasis 29(1):39–50

    Article  CAS  PubMed  Google Scholar 

  • Chui MH (2013) Insights into cancer metastasis from a clinicopathologic perspective: epithelial–mesenchymal transition is not a necessary step. Int J Cancer 132(7):1487–1495

    Article  CAS  PubMed  Google Scholar 

  • Cohen SJ, Punt CJ, Iannotti N et al (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26(19):3213–3221

    Article  PubMed  Google Scholar 

  • Coleman MP, Allemani C (2015) Cancer: the elephant in the room. Lancet 385(9973):1047–1048

    Article  PubMed  Google Scholar 

  • Fischer KR, Durrans A, Lee S et al (2015) Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527(7579):472–476

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Flores LM, Kindelberger DW, Ligon AH et al (2010) Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer. Br J Cancer 102(10):1495–1502

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Galván JA, Astudillo A, Vallina A et al (2014) Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors. BMC Cancer 14:855

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Giordano A, Gao H, Anfossi S et al (2012) Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer. Mol Cancer Ther 11(11):2526–2534

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gjerdrum C, Tiron C, Høiby T et al (2010) Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci USA 107(3):1124–1129

    Article  CAS  PubMed  Google Scholar 

  • Gorges TM, Tinhofer I, Drosch M et al (2012) Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. BMC Cancer 12:178

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Grande MT, Sanchez-Laorden B, Lopez-Blau C et al (2015) Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med 21(9):989–097

    Article  CAS  PubMed  Google Scholar 

  • Grigore AD, Jolly MK, Jia D, Farach-Carson MC, Levine H (2016) Tumor budding: the name is EMT. Partial EMT. J Clin Med 5(5). pii: E51

    Google Scholar 

  • Gunasinghe NP, Wells A, Thompson EW et al (2012) Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev 31(3–4):469–478

    Article  CAS  PubMed  Google Scholar 

  • Hamilton G, Rath B, Klameth L et al (2015a) Small cell lung cancer: recruitment of macrophages by circulating tumor cells. Oncoimmunology 5(3):e1093277

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hamilton G, Rath B, Klameth L et al (2015b) Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer. Oncoscience 2(7):629–634

    Article  PubMed  PubMed Central  Google Scholar 

  • Hamilton G, Burghuber O, Zeillinger R (2015c) Circulating tumor cells in small cell lung cancer: ex vivo expansion. Lung 193(3):451–452

    Article  PubMed  Google Scholar 

  • Hamilton G, Rath B, Ulsperger E (2015d) How to target small cell lung cancer. Oncoscience 2(8):684–692

    Article  PubMed  PubMed Central  Google Scholar 

  • Hamilton G, Moser D, Hochmeier M (2016a) Metastasis: circulating tumor cells in small cell lung cancer. Trend Cancer 2:159–160

    Article  Google Scholar 

  • Hamilton G, Rath B, Ulsperger E (2016b) A review of the role of surgery for small cell lung cancer and the potential prognostic value of enumeration of circulating tumor cells. Eur J Surg Oncol 42(9):1296–1302

    Article  CAS  PubMed  Google Scholar 

  • Hamilton G, Hochmair M, Rath B et al (2016c) Small cell lung cancer: circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype. Cell Adhes Migr 26:1–8

    Google Scholar 

  • Hamilton G, Rath B, Holzer S et al (2016d) Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cell. Transl Lung Cancer Res 5(1):71–77

    CAS  PubMed  PubMed Central  Google Scholar 

  • Harney AS, Arwert EN, Entenberg D et al (2015) Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov 5(9):932–943

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hensler M, Vancurova I, Becht E et al (2015) Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients. Oncoimmunology 5(4):e1102827

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hodgkinson CL, Morrow CJ, Li Y et al (2014) Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 20(8):897–903

    Article  CAS  PubMed  Google Scholar 

  • Hong B, Zu Y (2013) Detecting circulating tumor cells: current challenges and new trends. Theranostics 3(6):377–394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Huang RY, Guilford P, Thiery JP (2012) Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci 125(Pt 19):4417–4422

    Article  CAS  PubMed  Google Scholar 

  • Huang RY, Wong MK, Tan TZ et al (2013) An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 4:e915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jiménez Ruiz CA, Ramos Pinedo A, Cicero Guerrero A et al (2012) Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Nicotine Tob Res 14(9):1035103–1035109

    Article  CAS  Google Scholar 

  • Jolly MK, Boareto M, Huang B et al (2015) Implications of the hybrid epithelial/mesenchymal phenotype in metastasis Front. Oncologia 5:155

    Google Scholar 

  • Jordan NV, Johnson GL, Abell AN (2011) Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle 10(17):2865–2873

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kalemkerian GP (2014) Advances in pharmacotherapy of small cell lung cancer. Expert Opin Pharmacother 15(16):2385–2396

    Article  CAS  PubMed  Google Scholar 

  • Kallergi G, Papadaki MA, Politaki E et al (2011) Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res 13(3):R59

    Article  PubMed  PubMed Central  Google Scholar 

  • Kalluri R, Weinberg RA (2009) The basics of epithelial–mesenchymal transition. J Clin Invest 119(6):1420–1428

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khoo BL, Lee SC, Kumar P et al (2015) Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy. Oncotarget 6(17):15578–15593

    Article  PubMed  PubMed Central  Google Scholar 

  • Koinis F, Kotsakis A, Georgoulias V (2016) Small cell lung cancer (SCLC): no treatment advances in recent years. Transl Lung Cancer Res 5(1):39–50

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kölbl AC, Jeschke U, Andergassen U (2016) The significance of epithelial-to-mesenchymal transition for circulating tumor cells. Int J Mol Sci 17(8)

    Google Scholar 

  • Kong D, Banerjee S, Ahmad A et al (2010) Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 5(8):e12445

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Krohn A, Ahrens T, Yalcin A et al (2014) Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes. PLoS One 9(6):e100249

    Article  PubMed  PubMed Central  Google Scholar 

  • Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial- mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178–196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee JM, Dedhar S, Kalluri R et al (2006) The epithelialmesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172(7):973–981

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li W, Kang Y (2016) Probing the fifty shades of EMT in metastasis. Trend Cancer 2(2):65–67

    Article  Google Scholar 

  • Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y et al (2007) Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67(19):9066–9076

    Google Scholar 

  • Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K, Carstens JL et al (2015) Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med 21(9):998–1009

    Google Scholar 

  • Martowicz A, Spizzo G, Gastl G et al (2012) Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. BMC Cancer 12:501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meng S, Tripathy D, Frenkel EP et al (2004) Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 10(24):8152–8162

    Article  PubMed  Google Scholar 

  • Merikallio H, Turpeenniemi-Hujanen T, Pääkkö P et al (2012) Snail promotes an invasive phenotype in lung carcinoma. Respir Res 13:104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Milara J, Peiró T, Serrano A, Cortijo J (2013) Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax 68(5):410–420

    Article  PubMed  Google Scholar 

  • Mitra A, Mishra L, Li S (2015) EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 26(13):10697–10711

    Article  Google Scholar 

  • Mittal V (2016) Epithelial mesenchymal transition in aggressive lung cancers. Adv Exp Med Biol 890:37–56

    Article  PubMed  Google Scholar 

  • Nakazawa K, Kurishima K, Tamura T et al (2012) Specific organ metastases and survival in small cell lung cancer. Oncol Lett 4(4):617–620

    PubMed  PubMed Central  Google Scholar 

  • Nieto MA (2013) Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342(6159):1234850

    Article  PubMed  CAS  Google Scholar 

  • Nieto MA, Huang RY, Jackson RA et al (2016) EMT: 2016. Cell 166(1):21–45

    Article  CAS  PubMed  Google Scholar 

  • Ocana OH, Corcoles R, Fabra A et al (2012) Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22(6):709–724

    Article  CAS  PubMed  Google Scholar 

  • Peifer M, Fernández-Cuesta L, Sos ML et al (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44(10):1104–1110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7(6):415–428

    Article  CAS  PubMed  Google Scholar 

  • Pietanza MC, Byers LA, Minna JD et al (2015) Small cell lung cancer: will recent progress lead to improved outcomes? Clin Cancer Res 21(10):2244–2255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pietanza MC, Ladanyi M (2012) Bringing the genomic landscape of small-cell lung cancer into focus. Nat Genet 44(10):1074–1075

    Article  CAS  PubMed  Google Scholar 

  • Pillai RN, Owonikoko TK (2014) Small cell lung cancer: therapies and targets. Semin Oncol 41(1):133–142

    Article  CAS  PubMed  Google Scholar 

  • Polioudaki H, Agelaki S, Chiotaki R et al (2015) Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer 15:399

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pore M, Meijer C, de Bock GH et al (2016) Cancer stem cells, epithelial to mesenchymal markers, and circulating tumor cells in small cell lung cancer. Clin Lung Cancer S1525-7304(16):30131

    Google Scholar 

  • Rhim AD, Mirek ET, Aiello NM et al (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148(1–2):349–361

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Robinson BD, Sica GL, Liu YF et al (2009) Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15(7):2433–2441

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rolfo C, Castiglia M, Hong D et al (2014) Liquid biopsies in lung cancer: the new ambrosia of researchers. Biochim Biophys Acta 1846(2):539–546

    CAS  PubMed  Google Scholar 

  • Rosenblatt JI, Hokanson JA, McLaughlin SR et al (1997) Theoretical basis for sampling statistics useful for detecting and isolating rare cells using flow cytometry and cell sorting. Cytometry 27(3):233–238

    Article  CAS  PubMed  Google Scholar 

  • Rudin CM, Durinck S, Stawiski EW et al (2012) Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 44(10):1111–1116

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saitoh M, Endo K, Furuya S et al (2016) STAT3 integrates cooperative Ras and TGF-beta signals that induce Snail expression. Oncogene 35(8):1049–1057

    Article  CAS  PubMed  Google Scholar 

  • Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer Cancer. Metastasis Rev 28(1–2):151–166

    Article  CAS  Google Scholar 

  • Semenova EA, Nagel R, Berns A (2015) Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev 29(14):1447–1462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singh A, Settleman J (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29(34):4741–4751

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sohal SS, Walters EH (2013) Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD). Respir Res 14:120

    Article  PubMed  PubMed Central  Google Scholar 

  • Somarelli JA, Schaeffer D, Marengo MS et al (2016) Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways. Oncogene 35(33):4302–4311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spizzo G, Fong D, Wurm M et al (2011) EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. J Clin Pathol 64(5):415–420

    Article  PubMed  PubMed Central  Google Scholar 

  • Steeg PS (2016) Targeting metastasis. Nat Rev Cancer 16(4):201–218

    Article  CAS  PubMed  Google Scholar 

  • Tam WL, Weinberg RA (2013) The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 19(11):1438–1449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tan TZ, Miow QH, Miki Y et al (2014) Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med 6(10):1279–1293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tarin D, Thompson EW, Newgreen DF (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65(14):5996–6000

    Article  CAS  PubMed  Google Scholar 

  • Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6):442–454

    Article  CAS  PubMed  Google Scholar 

  • Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131–142

    Article  CAS  PubMed  Google Scholar 

  • Thiery JP, Acloque H, Huang RY et al (2009) Epithelial mesenchymal transitions in development and disease. Cell 139(5):871–890

    Article  CAS  PubMed  Google Scholar 

  • Thiery JP, Lim CT (2013) Tumor dissemination: an EMT affair cancer. Cell 23(3):272–273

    CAS  Google Scholar 

  • Tibbe AG, Miller MC, Terstappen LW (2007) Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71(3):154–162

    Article  PubMed  Google Scholar 

  • Tsai JH, Yang J (2013) Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27(20):2192–2206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsuji T, Ibaragi S, Shima K et al (2008) Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res 68(24):10377–10386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vanharanta S, Massague J (2013) Origins of metastatic traits. Cancer Cell 24:410–421

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vega S, Morales AV, Ocana OH et al (2004) Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18(10):1131–1143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vu T, Jin L, Datta PK (2016) Effect of cigarette smoking on Epithelial to Mesenchymal Transition (EMT) in lung cancer. J Clin Med 5(4):E44

    Article  PubMed  Google Scholar 

  • Wagenblast E, Soto M, Gutierrez-Angel S et al (2015) A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature 520(7547):358–362

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wan L, Pantel K, Kang Y (2013) Tumor metastasis: moving new biological insights into the clinic. Nat Med 19:1450–1464

    Article  CAS  PubMed  Google Scholar 

  • Weiswald LB, Bellet D, Dangles-Marie V (2015) Spherical cancer models in tumor biology. Neoplasia 17(1):1–15

    Article  PubMed  PubMed Central  Google Scholar 

  • Wyckoff J, Wang W, Lin EY et al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64(19):7022–7029

    Article  CAS  PubMed  Google Scholar 

  • Ye X, Weinberg RA (2015) Epithelial-mesenchymal plasticity: a central regulator of cancer progression trends. Cell Biol 25(11):675–686

    Article  CAS  Google Scholar 

  • Yu M, Bardia A, Wittner BS et al (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119):580–584

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu N, Zhou J, Cui F, Tang X (2015) Circulating tumor cells in lung cancer: detection methods and clinical applications. Lung 193(2):157–171

    Article  CAS  PubMed  Google Scholar 

  • Zheng X, Carstens JL, Kim J et al (2015) Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527(7579):525–530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Society for Research on Biology and Treatment of Cancer (SRBTC), A-1160, Vienna, Austria

    Gerhard Hamilton & Barbara Rath

Authors
  1. Gerhard Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Rath
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerhard Hamilton .

Editor information

Editors and Affiliations

  1. University of California San Francisco, San Francisco, California, USA

    Mark Jesus M. Magbanua

  2. University of California San Francisco, San Francisco, California, USA

    John W. Park

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Hamilton, G., Rath, B. (2017). Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer. In: Magbanua, M., Park, J. (eds) Isolation and Molecular Characterization of Circulating Tumor Cells. Advances in Experimental Medicine and Biology, vol 994. Springer, Cham. https://doi.org/10.1007/978-3-319-55947-6_12

Download citation

Publish with us

Policies and ethics

Search

Navigation